as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹868.65
Change
+15.65 (1.83%)
Open
₹856.9
Prev. Close
₹853.0
Day High
₹875.0
Day Low
₹849.05
Volume Analysis
Traded
597,420
Delivered
280,684
Delivery %
46.98%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (23.0%)
Weaknesses (1)
- •Promoter holding is falling
Opportunities (1)
- •FII holding has been rising
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹905.36 | ₹890.18 | ₹879.41 | ₹864.23 | ₹853.46 | ₹838.28 | ₹827.51 |
| Fibonacci | ₹890.18 | ₹880.27 | ₹874.14 | ₹864.23 | ₹854.32 | ₹848.19 | ₹838.28 |
| Camarilla | ₹875.79 | ₹873.41 | ₹871.03 | ₹864.23 | ₹866.27 | ₹863.89 | ₹861.51 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+40.29%
1 Week
-0.74%
1 Month
+3.82%
3 Months
+6.81%
6 Months
+38.3%
1 Year
+68.38%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹332.79
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
12.42%
Net margin 11.75% × asset turnover 0.7x × equity multiplier 1.51x
Company Overview
Sector
Healthcare
Market Cap
₹23,248 Cr
P/E (TTM)
35.8
ROE
13.8%
Book Value
₹205.0
Face Value
₹1.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Granules India Limited holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 65/100. The strongest factor is Financial Strength (100/100), while Growth (27/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (23.0%); promoter holding is falling. FII holding has been rising.
TopFund Score — Fundamentals Quality
65/100 — GoodData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Promoter holding has decreased over last quarter: -0.63%
- −The company has delivered a poor sales growth of 10.6% over past five years.
- −Company has a low return on equity of 13.6% over last 3 years.
- −Company might be capitalizing the interest cost
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Granules India to meet analysts and investors on September 28, 2026 in New Delhi.
Granules allotted 2.50 crore equity shares on 16 Sep 2026 via warrant conversion, raising ₹1,461.5 crore.
Promoters paid ₹1,093 crore balance for warrants; 2.49 crore warrants now convertible, boosting net cash.
Promoter Krishna Prasad Chigurupati sold 1.72 crore Granules India shares in a block deal on 11 September 2026.
Promoter sold 1.72 crore shares on Sept. 11; promoter group holding fell to 31.08%.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 986 | 1,189 | 1,156 | 1,176 | 1,180 | 967 | 1,138 | 1,197 | 1,210 | 1,297 | 1,388 | 1,471 | 1,477 |
| Expenses + | 849 | 977 | 905 | 920 | 921 | 763 | 907 | 945 | 963 | 1,019 | 1,080 | 1,119 | 1,138 |
| Operating Profit | 137 | 213 | 250 | 256 | 259 | 203 | 230 | 252 | 247 | 278 | 308 | 352 | 339 |
| OPM % | 14.0% | 18.0% | 22.0% | 22.0% | 22.0% | 21.0% | 20.0% | 21.0% | 20.0% | 21.0% | 22.0% | 24.0% | 23.0% |
| Other Income + | 0 | 2 | 1 | 2 | 2 | 3 | 6 | 33 | -10 | -1 | -4 | 25 | 2 |
| Interest | 22 | 26 | 29 | 29 | 27 | 26 | 27 | 24 | 24 | 29 | 29 | 33 | 21 |
| Depreciation | 49 | 53 | 52 | 53 | 53 | 53 | 57 | 64 | 69 | 72 | 74 | 82 | 80 |
| Profit before tax | 65 | 136 | 170 | 176 | 181 | 128 | 153 | 198 | 145 | 176 | 202 | 262 | 240 |
| Tax % | 27.0% | 25.0% | 26.0% | 26.0% | 26.0% | 24.0% | 23.0% | 23.0% | 22.0% | 26.0% | 26.0% | 23.0% | 25.0% |
| Net Profit + | 48 | 102 | 126 | 130 | 135 | 97 | 118 | 152 | 113 | 131 | 150 | 202 | 180 |
| EPS in Rs | 2 | 4 | 5 | 5 | 6 | 4 | 5 | 6 | 5 | 5 | 6 | 8 | 7 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,292 | 1,357 | 1,411 | 1,685 | 2,279 | 2,599 | 3,238 | 3,765 | 4,512 | 4,506 | 4,482 | 5,366 | 5,632 |
| Expenses + | 1,082 | 1,081 | 1,112 | 1,406 | 1,895 | 2,073 | 2,382 | 3,038 | 3,597 | 3,648 | 3,534 | 4,177 | 4,355 |
| Operating Profit | 210 | 276 | 299 | 278 | 384 | 526 | 856 | 727 | 915 | 858 | 948 | 1,188 | 1,277 |
| OPM % | 16.0% | 20.0% | 21.0% | 17.0% | 17.0% | 20.0% | 26.0% | 19.0% | 20.0% | 19.0% | 21.0% | 22.0% | 23.0% |
| Other Income + | 3 | 5 | 35 | 27 | 75 | 90 | 26 | 13 | 12 | 2 | 41 | 7 | 22 |
| Interest | 32 | 37 | 32 | 33 | 28 | 27 | 26 | 23 | 56 | 106 | 103 | 114 | 112 |
| Depreciation | 53 | 58 | 72 | 76 | 105 | 137 | 151 | 159 | 184 | 207 | 226 | 296 | 307 |
| Profit before tax | 128 | 186 | 230 | 196 | 326 | 451 | 704 | 558 | 687 | 547 | 660 | 785 | 881 |
| Tax % | 29.0% | 33.0% | 28.0% | 32.0% | 27.0% | 26.0% | 22.0% | 26.0% | 25.0% | 26.0% | 24.0% | 24.0% | — |
| Net Profit + | 91 | 123 | 165 | 133 | 236 | 335 | 549 | 413 | 517 | 405 | 502 | 595 | 662 |
| EPS in Rs | 4 | 6 | 7 | 5 | 9 | 13 | 22 | 17 | 21 | 17 | 21 | 24 | 27 |
| Dividend Payout % | 11.0% | 11.0% | 13.0% | 19.0% | 11.0% | 8.0% | 7.0% | 9.0% | 7.0% | 9.0% | 7.0% | 7.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 411 | 640 | 881 | 1,279 | 1,504 | 1,818 | 2,149 | 2,562 | 2,811 | 3,201 | 3,691 | 5,060 |
| Borrowings + | 482 | 641 | 656 | 978 | 991 | 892 | 849 | 1,106 | 1,136 | 1,315 | 1,455 | 1,512 |
| Other Liabilities + | 289 | 260 | 319 | 388 | 458 | 487 | 690 | 819 | 932 | 957 | 1,051 | 1,086 |
| Total Liabilities | 1,203 | 1,563 | 1,879 | 2,670 | 2,979 | 3,223 | 3,713 | 4,512 | 4,903 | 5,498 | 6,221 | 7,683 |
| Fixed Assets + | 617 | 560 | 644 | 777 | 944 | 1,204 | 1,332 | 1,541 | 1,911 | 2,096 | 2,426 | 3,250 |
| CWIP | 62 | 77 | 267 | 515 | 496 | 294 | 239 | 356 | 239 | 272 | 440 | 410 |
| Investments | 0 | 70 | 108 | 157 | 210 | 19 | 19 | 20 | 21 | 22 | 22 | 1 |
| Other Assets + | 524 | 856 | 859 | 1,222 | 1,328 | 1,706 | 2,123 | 2,594 | 2,732 | 3,109 | 3,333 | 4,022 |
| Total Assets | 1,203 | 1,563 | 1,879 | 2,670 | 2,979 | 3,223 | 3,713 | 4,512 | 4,903 | 5,498 | 6,221 | 7,683 |
| Equity Capital | 20 | 22 | 23 | 25 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 25 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 150 | 151 | 188 | -1 | 262 | 476 | 432 | 332 | 739 | 439 | 867 | 793 |
| Cash from Investing Activity + | -146 | -162 | -326 | -462 | -270 | -160 | -277 | -379 | -192 | -358 | -689 | -758 |
| Cash from Financing Activity + | 19 | 86 | 56 | 529 | -17 | -213 | -299 | 190 | -440 | 8 | -93 | 379 |
| Net Cash Flow | 24 | 75 | -82 | 66 | -25 | 103 | -144 | 143 | 107 | 90 | 85 | 414 |
| CFO/OP | 87 | 72 | 83 | 21 | 91 | 113 | 73 | 66 | 100 | 73 | 107 | 87 |
| Free Cash Flow | 3 | -10 | -127 | -447 | -17 | 292 | 161 | -65 | 328 | 61 | 297 | 239 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 29.1% | 27.77% | 26.61% | 26.8% | 25.71% | 23.56% | 24.41% | 29.17% | 30.15% | 29.67% | 28.36% | 26.93% |
| Promoters | 41.97% | 41.96% | 38.87% | 38.87% | 38.85% | 38.83% | 38.82% | 38.81% | 38.81% | 38.02% | 38.01% | 37.39% |
| FII | 18.78% | 19.57% | 20.39% | 19.49% | 15.87% | 15.14% | 13.24% | 14.09% | 13.55% | 15.31% | 17.5% | 20.29% |
| DII | 10.16% | 10.7% | 14.11% | 14.85% | 19.57% | 22.45% | 23.52% | 17.91% | 17.47% | 17.01% | 16.11% | 15.4% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Granules India Limited (this stock) | 23,248 | 35.8 | 4.16 | 13.8% |
| Caplin Point Lab Ltd. | 21,506 | 32.3 | 6.39 | 20.9% |
| Shilpa Medicare Ltd | 19,821 | 69.7 | 7.67 | 8.99% |
| Acutaas Chemicals Limited | 26,884 | 69.6 | 16.26 | 24.0% |
| Rubicon Research Limited | 27,748 | 96.3 | 21.46 | 27.0% |
| Piramal Pharma Limited | 28,000 | — | 3.42 | -3.83% |
| Neuland Lab Ltd. | 28,085 | 56.4 | 14.98 | 21.2% |
Which Mutual Funds Hold Granules India Limited?
Frequently Asked Questions about Granules India Limited
Granules India Limited (GRANULES) closed at ₹868.65 on NSE on 25 September 2026, up 15.65 (1.83%) from the previous close.
Granules India Limited trades on the NSE (National Stock Exchange of India) under the symbol GRANULES.
Granules India Limited has a trailing twelve-month P/E (price-to-earnings) ratio of 35.8.
Granules India Limited has a dividend yield of 0.21%.
Granules India Limited's 52-week high is ₹924.0 and its 52-week low is ₹511.0.
Granules India Limited has a market capitalisation of ₹23,248 crore.
Granules India Limited has a TopFund Quality Score of 65/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Granules India Limited?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.